# Bed Bath & Beyond share price (Bed Bath & Beyond, Inc., BBBY)

> Bed Bath & Beyond, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. BBBY · Consumer Discretionary · Specialty Retail · data as of 14 August 2026. Page: https://www.sectoralpha.in/us/stocks/bbby

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: $4.35 (−50.8% in a year)
- Revenue (Mar 2026): $248 M (+6.9% on a year ago)
- Profit (Mar 2026): −$16.4 M
- Operating margin: −7.3% (+2.7 points on a year ago)
- ROE: −39%, FY25
- ROIC: −40.7%, against a 14.9% cost of capital: −55.6 points

Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. ## What is the Bed Bath & Beyond share price? Bed Bath & Beyond, Inc.'s share price was $4.35 at the close on 14 August 2026. That is 23.0% below its average price over the last 200 trading days. In the last 52 weeks it traded between $4 and $12, and at that close it was at the low of that range. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 5 weeks running. Over the last 1 year the share price moved −44% while the S&P 500 moved +24%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 10 July 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Bed Bath & Beyond pay? Bed Bath & Beyond, Inc. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is Bed Bath & Beyond on? Bed Bath & Beyond is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Bed Bath & Beyond profitable? Bed Bath & Beyond, Inc. posted a net loss of $16.4 M in the Mar 2026 quarter. The full FY25 year was a loss of $84.6 M. That loss is 6.6% of the quarter's revenue. The same quarter a year earlier lost $39.9 M. 12 of the last 12 reported quarters were loss-making. ## How much revenue does Bed Bath & Beyond make, and is it growing? Bed Bath & Beyond, Inc. reported $248 M of revenue in the Mar 2026 quarter, +6.9% on the same quarter a year earlier. Over 4 years it has grown −21.5% a year on average. The last full year, FY25, came in at $1.0 B. The last four reported quarters add to $1.1 B. FY25 revenue was $1.0 B, −25.1% on the year before. Recent pace: the last four quarters grew −12.3% on average, against −21.5% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew −14.8%, against −17.6% a year over the last 8 quarters (stabilising). ## How much of every $100 of sales does Bed Bath & Beyond keep? Bed Bath & Beyond, Inc.'s operating margin was −7.3% in the Mar 2026 quarter, 2.7 percentage points higher than the same quarter a year ago. Across 5 years it has been between −13.2% and 4.0%. The latest quarter is within that range. Why the margin moved: operating margin changed +2.7 percentage points on the year while gross margin changed −1.2 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is Bed Bath & Beyond's profit turning into cash? Bed Bath & Beyond, Inc.'s cash-flow history is too short to judge how much of its profit turns into cash. In FY25 its operations used $56.7 M of cash, against −$84.6 M of profit. After $7.4 M of spending on assets, free cash was −$64.1 M: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Bed Bath & Beyond's cash go? Bed Bath & Beyond, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $40.9 M on assets over the last 3 years. Averaged over those years that is 1.3% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $40.9 M over the last 3 years. In short: most of the cash goes on covering the loss, not on new assets; spending on assets is small next to it. ## What is Bed Bath & Beyond's P/E ratio, and how does it compare with its own history? Bed Bath & Beyond, Inc. has no P/E right now, because its earnings are negative. The revenue and margin sections are where a turn would show first. Measured against sales instead, the market values Bed Bath & Beyond, Inc. at 0.4× its FY25 revenue of $1.0 B. The P/E comes back here once profit turns positive. ## Is the Bed Bath & Beyond business getting better or worse? Bed Bath & Beyond, Inc.'s business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 12 quarters of 2 measures, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Bed Bath & Beyond earn on its capital? Bed Bath & Beyond, Inc. earned a ROE of −39% in FY25. That is up from a low of −159% in FY24. Its return on capital used (ROIC) is 55.6 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a −8.1% net margin and 2.46× asset turnover (sales divided by assets). Why the return is what it is (FY25): a −8.1% net margin × 2.46× asset turnover × 1.95× leverage (assets divided by equity) ≈ −38.9% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: −40.7% − 14.9% = −55.6 percentage points. The 14.9% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. The −40.7% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at −262.5%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Bed Bath & Beyond have too much debt? Bed Bath & Beyond, Inc. has total debt of $21.9 M against shareholder equity of $202 M as of Mar 2026, so its debt is 0.11× its equity, which is very little. Year by year, that ratio went from 0.25 in FY21 to 0.10 in FY25. So the returns on this page come from the business, not from borrowed money. ## What is the Bed Bath & Beyond shareholding pattern? We have no ownership or short-position figures for Bed Bath & Beyond, Inc., so this section says so rather than fill the gap. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. ## How far is Bed Bath & Beyond from balance-sheet trouble? For Bed Bath & Beyond, Inc., the Z-score is −0.06. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the danger zone. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of −0.06 is inside the danger zone, so the balance sheet is a real risk. ## How does Bed Bath & Beyond rank in its industry? 38.8 out of 100, rank 28 of 28 in Specialty Retail, with 31% of the evidence available. It is provisional, so it is ranked below companies with full evidence. Bed Bath & Beyond, Inc. scores 38.8 out of 100 against the 28 companies it is compared with in Specialty Retail, ranking 28. Some evidence is missing, so the score is pulled toward the middle on purpose. The three scored parts add up to the total exactly: 20.1 + 7.9 + 10.8 = 38.8 (no relative-strength reading this week; its 20 points are shared across the other three). This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Bed Bath & Beyond compared with? Bed Bath & Beyond ranks 28 of 28 Specialty Retail companies on the 4-Factor Sector Score, with 38.8 out of 100. 1. [Five Below, Inc.](https://www.sectoralpha.in/us/stocks/five) FIVE · losing its lead · Most evidence points up · 85% evidence 72.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 32.1/35 · Revenue 25.5% · Profit 100% · Operating margin change 3.8 points · 95% evidence Capital efficiency 15.1/25 · ROCE 14.5% · Operating margin 8.9% · 76% evidence Valuation 13.5/20 · P/E 19.4× · PEG 0.72 · 65% evidence Relative strength 11.3/20 · Lead over its industry 4.5% · Lead over S&P 500 6.7% · 1 year 55.1% · 100% evidence · 10 of 12 weeks ahead Exact sum: 32.1 + 15.1 + 13.5 + 11.3 = 72 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Best Buy Co., Inc.](https://www.sectoralpha.in/us/stocks/bby) BBY · leader · Most evidence points up · 85% evidence 70.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.0/35 · Revenue 1.4% · Profit 63.5% · Operating margin change 0 points · 95% evidence Capital efficiency 17.2/25 · ROCE 25.4% · Operating margin 3.9% · 76% evidence Valuation 15.6/20 · P/E 14.3× · PEG 0.35 · 65% evidence Relative strength 17.4/20 · Lead over its industry 16.3% · Lead over S&P 500 19% · 1 year 18.8% · 100% evidence · 10 of 12 weeks ahead Exact sum: 20 + 17.2 + 15.6 + 17.4 = 70.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Academy Sports and Outdoors, Inc.](https://www.sectoralpha.in/us/stocks/aso) ASO · breaking out · Most evidence points up · 85% evidence 68.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.8/35 · Revenue 3.7% · Profit 7% · Operating margin change 4.2 points · 95% evidence Capital efficiency 15.2/25 · ROCE 13.3% · Operating margin 15% · 76% evidence Valuation 14.9/20 · P/E 7.4× · PEG 0.6 · 65% evidence Relative strength 16.5/20 · Lead over its industry 7.9% · Lead over S&P 500 9.7% · 1 year 33% · 100% evidence · 6 of 12 weeks ahead Exact sum: 21.8 + 15.2 + 14.9 + 16.5 = 68.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Murphy USA Inc.](https://www.sectoralpha.in/us/stocks/musa) MUSA · turning · Evidence leans up · 81% evidence 62.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.0/35 · Revenue 11.3% · Profit 25.7% · Operating margin change -0.1 points · 83% evidence Capital efficiency 16.8/25 · ROCE 23.5% · Operating margin 4.9% · 76% evidence Valuation 14.8/20 · P/E 16.1× · PEG 0.45 · 65% evidence Relative strength 7.1/20 · Lead over its industry -3.9% · Lead over S&P 500 -1.6% · 1 year 40.1% · 100% evidence · 0 of 12 weeks ahead Exact sum: 24 + 16.8 + 14.8 + 7.1 = 62.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Bath & Body Works, Inc.](https://www.sectoralpha.in/us/stocks/bbwi) BBWI · turning · Evidence leans up · 85% evidence 61.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 10.4/35 · Revenue -2.2% · Profit 7.3% · Operating margin change -1.5 points · 95% evidence Capital efficiency 18.9/25 · ROCE 31.1% · Operating margin 9.6% · 76% evidence Valuation 15.9/20 · P/E 5.2× · PEG 0.36 · 65% evidence Relative strength 16.0/20 · Lead over its industry 6% · Lead over S&P 500 7.7% · 1 year -1.3% · 100% evidence · 4 of 12 weeks ahead Exact sum: 10.4 + 18.9 + 15.9 + 16 = 61.2 · What this means: Relative strength against the index is 7.7%, and revenue and profit growth are weak. 6. [Ulta Beauty, Inc.](https://www.sectoralpha.in/us/stocks/ulta) ULTA · breaking out · Evidence leans up · 85% evidence 57.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.7/35 · Revenue 11.2% · Profit 0.8% · Operating margin change 0.1 points · 95% evidence Capital efficiency 19.7/25 · ROCE 34.5% · Operating margin 12.5% · 76% evidence Valuation 5.7/20 · P/E 18.2× · PEG 3.52 · 65% evidence Relative strength 15.3/20 · Lead over its industry 5.8% · Lead over S&P 500 7.4% · 1 year 22.6% · 100% evidence · 10 of 12 weeks ahead Exact sum: 16.7 + 19.7 + 5.7 + 15.3 = 57.4 · What this means: Relative strength against the index is 7.4%, and revenue and profit growth are weak. 7. [GameStop Corp.](https://www.sectoralpha.in/us/stocks/gme) GME · breaking out · Evidence leans up · 75% evidence 57.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.7/35 · Revenue -7.7% · Profit 100% · Operating margin change 13.4 points · 95% evidence Capital efficiency 9.6/25 · ROCE 4.7% · Operating margin 20% · 76% evidence Valuation 10.7/20 · P/E 10.9× · PEG n/a · 15% evidence Relative strength 13.4/20 · Lead over its industry 0.8% · Lead over S&P 500 2.7% · 1 year 12.9% · 100% evidence · 5 of 12 weeks ahead Exact sum: 23.7 + 9.6 + 10.7 + 13.4 = 57.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Sally Beauty Holdings, Inc.](https://www.sectoralpha.in/us/stocks/sbh) SBH · leader · Evidence leans up · 81% evidence 55.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 14.2/35 · Revenue 1.1% · Profit -0.5% · Operating margin change 0.8 points · 83% evidence Capital efficiency 13.6/25 · ROCE 12.5% · Operating margin 9.3% · 76% evidence Valuation 11.9/20 · P/E 7× · PEG 1.28 · 65% evidence Relative strength 15.5/20 · Lead over its industry 10.4% · Lead over S&P 500 12.5% · 1 year 27.8% · 100% evidence · 11 of 12 weeks ahead Exact sum: 14.2 + 13.6 + 11.9 + 15.5 = 55.2 · What this means: Relative strength against the index is 12.5%, and revenue and profit growth are weak. 9. [Williams-Sonoma, Inc.](https://www.sectoralpha.in/us/stocks/wsm) WSM · losing its lead · Evidence leans up · 85% evidence 54.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.2/35 · Revenue 2.2% · Profit 4.6% · Operating margin change -0.6 points · 95% evidence Capital efficiency 20.7/25 · ROCE 39.6% · Operating margin 17.3% · 76% evidence Valuation 6.6/20 · P/E 22.8× · PEG 2.67 · 65% evidence Relative strength 14.1/20 · Lead over its industry 12.9% · Lead over S&P 500 15.3% · 1 year 28.8% · 100% evidence · 7 of 12 weeks ahead Exact sum: 13.2 + 20.7 + 6.6 + 14.1 = 54.6 · What this means: Relative strength against the index is 15.3%, and revenue and profit growth are weak. 10. [Casey's General Stores, Inc.](https://www.sectoralpha.in/us/stocks/casy) CASY · quiet · Evidence leans up · 85% evidence 52.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.2/35 · Revenue 13.8% · Profit 33% · Operating margin change -0.2 points · 95% evidence Capital efficiency 14.0/25 · ROCE 14.3% · Operating margin 6.5% · 76% evidence Valuation 10.2/20 · P/E 41.7× · PEG 1.25 · 65% evidence Relative strength 3.4/20 · Lead over its industry -12.1% · Lead over S&P 500 -10.2% · 1 year 24.7% · 100% evidence · 0 of 12 weeks ahead Exact sum: 25.2 + 14 + 10.2 + 3.4 = 52.8 · What this means: Earnings are strong; relative strength in its sector is -12.1% and the one-year return is 24.7%. 11. [Arhaus, Inc.](https://www.sectoralpha.in/us/stocks/arhs) ARHS · leader · Evidence leans up · 81% evidence 52.6 out of 100 Growth Capital Valuation Relative
12. [Barnes & Noble Education, Inc.](https://www.sectoralpha.in/us/stocks/bned) BNED · turning · Evidence leans up · 67% evidence 52.2 out of 100 Growth Capital Valuation Relative
13. [MarineMax, Inc.](https://www.sectoralpha.in/us/stocks/hzo) HZO · leader · Evidence leans up · 64% evidence 50.3 out of 100 Growth Capital Valuation Relative
14. [ChargePoint Holdings, Inc.](https://www.sectoralpha.in/us/stocks/chpt) CHPT · breaking out · Evidence leans down · 64% evidence 49.1 out of 100 Growth Capital Valuation Relative
15. [Winmark Corporation](https://www.sectoralpha.in/us/stocks/wina) WINA · basing · Evidence leans down · 85% evidence 45.8 out of 100 Growth Capital Valuation Relative
16. [Build-A-Bear Workshop, Inc.](https://www.sectoralpha.in/us/stocks/bbw) BBW · basing · Evidence leans down · 85% evidence 42.2 out of 100 Growth Capital Valuation Relative
17. [EVgo, Inc.](https://www.sectoralpha.in/us/stocks/evgo) EVGO · turning · Evidence leans down · 64% evidence 42.2 out of 100 Growth Capital Valuation Relative
18. [Savers Value Village, Inc.](https://www.sectoralpha.in/us/stocks/svv) SVV · quiet · Too little evidence to rank firmly · 58% evidence 42.2 out of 100 Growth Capital Valuation Relative
19. [National Vision Holdings, Inc.](https://www.sectoralpha.in/us/stocks/eye) EYE · quiet · Too little evidence to rank firmly · 58% evidence 40.9 out of 100 Growth Capital Valuation Relative
20. [Petco Health and Wellness Company, Inc.](https://www.sectoralpha.in/us/stocks/woof) WOOF · basing · Evidence leans down · 67% evidence 38.2 out of 100 Growth Capital Valuation Relative
21. [Tractor Supply Company](https://www.sectoralpha.in/us/stocks/tsco) TSCO · losing its lead · Evidence leans down · 85% evidence 37.9 out of 100 Growth Capital Valuation Relative
22. [RH](https://www.sectoralpha.in/us/stocks/rh) RH · basing · Most evidence points down · 85% evidence 34.8 out of 100 Growth Capital Valuation Relative
23. [DICK'S Sporting Goods, Inc.](https://www.sectoralpha.in/us/stocks/dks) DKS · basing · Most evidence points down · 85% evidence 30.9 out of 100 Growth Capital Valuation Relative
24. [Arko Corp.](https://www.sectoralpha.in/us/stocks/arko) ARKO · basing · Most evidence points down · 81% evidence 26.9 out of 100 Growth Capital Valuation Relative
25. 1-800-FLOWERS.COM, Inc. FLWS · basing · Most evidence points down · 64% evidence 26.5 out of 100 Growth Capital Valuation Relative
26. [Bob's Discount Furniture, Inc.](https://www.sectoralpha.in/us/stocks/bobs) BOBS · quiet · Too little evidence to rank firmly · 36% evidence 61.9 out of 100 Growth Capital Valuation Relative
27. [Olaplex Holdings, Inc.](https://www.sectoralpha.in/us/stocks/olpx) OLPX · Too little evidence to rank firmly · 31% evidence 39.9 out of 100 Growth Capital Valuation Relative
28. Bed Bath & Beyond, Inc. this page BBBY · Too little evidence to rank firmly · 31% evidence 38.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.1/43.75 · Revenue -14.8% · Profit n/a · Operating margin change 2.7 points · 40% evidence Capital efficiency 7.9/31.25 · ROCE -9.8% · Operating margin -7.3% · 57% evidence Valuation 10.8/25 · P/E 121.8× · PEG n/a · 15% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 20.1 + 7.9 + 10.8 = 38.8 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Specialty Retail](https://www.sectoralpha.in/us/sectors/specialty-retail), all 28 compared on one page. ## Which companies are close to Bed Bath & Beyond in size? Bed Bath & Beyond is the 27th largest of 29 Specialty Retail companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Betterware de México, S.A.P.I. de C.V., EVgo, Inc., Barnes & Noble Education, Inc. and Arko Corp. Just below it: Build-A-Bear Workshop, Inc. and ChargePoint Holdings, Inc. ### Specialty Retail companies close in size

1. [Betterware de México, S.A.P.I. de C.V.](https://www.sectoralpha.in/us/stocks/bwmx) $680 million
2. [EVgo, Inc.](https://www.sectoralpha.in/us/stocks/evgo) $576 million
3. [Barnes & Noble Education, Inc.](https://www.sectoralpha.in/us/stocks/bned) $433 million
4. [Arko Corp.](https://www.sectoralpha.in/us/stocks/arko) $431 million
5. Bed Bath & Beyond, Inc. $415 million
6. [Build-A-Bear Workshop, Inc.](https://www.sectoralpha.in/us/stocks/bbw) $355 million
7. [ChargePoint Holdings, Inc.](https://www.sectoralpha.in/us/stocks/chpt) $290 million

[All 29 Specialty Retail companies, largest first](https://www.sectoralpha.in/us/sectors/specialty-retail#all-companies)

### Companies close in size in other industries

1. [Materialise NV](https://www.sectoralpha.in/us/stocks/mtls) $415 million · Software - Application
2. [AdvanSix Inc.](https://www.sectoralpha.in/us/stocks/asix) $415 million · Chemicals
3. Bed Bath & Beyond, Inc. $415 million
4. [C4 Therapeutics, Inc.](https://www.sectoralpha.in/us/stocks/cccc) $415 million · Biotechnology
5. [XMax Inc.](https://www.sectoralpha.in/us/stocks/xmax) $414 million · Furnishings, Fixtures & Appliances

## What else do people ask about Bed Bath & Beyond? ### What were Bed Bath & Beyond's latest quarterly results? Bed Bath & Beyond, Inc. reported revenue of $248 M and a net loss of $16.4 M for the Mar 2026 quarter. Earnings per share were −$0.24. The operating margin was −7.3%, 2.7 percentage points higher than a year earlier (as of 14 August 2026). ### What is Bed Bath & Beyond's market cap? Bed Bath & Beyond, Inc.'s market capitalisation is $415 M at a stock price of $4.35. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 14 August 2026). ### How is Bed Bath & Beyond performing? Bed Bath & Beyond, Inc.'s latest readings are below. Over the past 13 weeks it has done worse than the S&P 500, for 5 weeks running. This describes what the data did, not a rating (as of 14 August 2026). ### Will Bed Bath & Beyond's stock price go up? This page does not forecast Bed Bath & Beyond, Inc.'s stock price. What it shows instead: the stock price is $4.35. Nobody can reliably say which way a price will move, and this site does not try (as of 14 August 2026). ### Does Bed Bath & Beyond have too much debt? Bed Bath & Beyond, Inc. has a moderate amount of debt: its debt is 0.71× its equity. A year-by-year history of its borrowings is not in our data, so this uses the latest reading. Keep that borrowing in mind when reading the returns on this page (as of 14 August 2026). ### Where is Bed Bath & Beyond in its business cycle? Bed Bath & Beyond, Inc.'s FY25 operating margin was −5.9%, against a 5-year range of −13.2% to 4.0%: the middle of its own range, neither a peak nor a low. The latest quarter was −7.3%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 14 August 2026). ### What could break the Bed Bath & Beyond story? Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 14 August 2026). ### Is Bed Bath & Beyond a stock worth studying right now? What the numbers show: Bed Bath & Beyond, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 14 August 2026). This is research, not advice. We’re not SEBI-registered.